A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir
Clinical trial NCT02961660 · COMPLETED
Trial details
- NCT number
- NCT02961660
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2018-04-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.